WO2008087365A3 - Derives de 1,3-diphenylpropane substitues, preparations et utilisations - Google Patents
Derives de 1,3-diphenylpropane substitues, preparations et utilisations Download PDFInfo
- Publication number
- WO2008087365A3 WO2008087365A3 PCT/FR2007/052632 FR2007052632W WO2008087365A3 WO 2008087365 A3 WO2008087365 A3 WO 2008087365A3 FR 2007052632 W FR2007052632 W FR 2007052632W WO 2008087365 A3 WO2008087365 A3 WO 2008087365A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- substituted
- preparations
- same
- diphenylpropane derivatives
- diphenylpropane
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C251/48—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/708—Ethers
- C07C69/712—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention concerne des composés dérivés de 1,3-diphénylpropane substitués, les compositions pharmaceutiques les comprenant ainsi que leurs applications thérapeutiques, notamment dans les domaines de la santé humaine et animale.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0656066 | 2006-12-29 | ||
FR0656066A FR2910892A1 (fr) | 2006-12-29 | 2006-12-29 | Derives de 1,3-diphenylpropane substitues, preparations et utilisations. |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008087365A2 WO2008087365A2 (fr) | 2008-07-24 |
WO2008087365A3 true WO2008087365A3 (fr) | 2008-11-27 |
Family
ID=38325647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2007/052632 WO2008087365A2 (fr) | 2006-12-29 | 2007-12-28 | Derives de 1,3-diphenylpropane substitues, preparations et utilisations |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR2910892A1 (fr) |
WO (1) | WO2008087365A2 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011107494A1 (fr) | 2010-03-03 | 2011-09-09 | Sanofi | Nouveaux dérivés aromatiques de glycoside, médicaments contenants ces composés, et leur utilisation |
EP2582709B1 (fr) | 2010-06-18 | 2018-01-24 | Sanofi | Dérivés d'azolopyridin-3-one en tant qu'inhibiteurs de lipases et de phospholipases |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
WO2013037390A1 (fr) | 2011-09-12 | 2013-03-21 | Sanofi | Dérivés amides d'acide 6-(4-hydroxyphényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase |
EP2760862B1 (fr) | 2011-09-27 | 2015-10-21 | Sanofi | Dérivés d'amide d'acide 6-(4-hydroxyphényl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique utilisés comme inhibiteurs de kinase |
AU2012360796B2 (en) * | 2011-12-28 | 2017-02-02 | Genfit | 1,3-diphenylpropane derivatives, preparations and uses thereof |
CN108658908B (zh) * | 2017-07-31 | 2019-05-10 | 广州必贝特医药技术有限公司 | 1,3-二取代烯酮类化合物及其应用 |
CN114901641A (zh) * | 2020-02-28 | 2022-08-12 | 四川科伦博泰生物医药股份有限公司 | 芳香族化合物及其药物组合物和用途 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005073184A1 (fr) * | 2004-01-08 | 2005-08-11 | Genfit | Composes derives de 1,3-diphenylprop-2-en-1-one, preparation et utilisations |
WO2006041197A1 (fr) * | 2004-10-14 | 2006-04-20 | Nippon Chemiphar Co., Ltd. | AGENT ACTIVANT DU RÉCEPTEUR δ ACTIVÉ PAR LES PROLIFÉRATEURS DE PEROXYSOME |
FR2882359A1 (fr) * | 2005-02-24 | 2006-08-25 | Negma Lerads Soc Par Actions S | Derives activateurs de ppar, procede de preparation et application en therapeutique |
CN1861560A (zh) * | 2005-05-13 | 2006-11-15 | 中国科学院上海药物研究所 | 一类羧酸衍生物,其制备方法及药物组合物 |
-
2006
- 2006-12-29 FR FR0656066A patent/FR2910892A1/fr not_active Withdrawn
-
2007
- 2007-12-28 WO PCT/FR2007/052632 patent/WO2008087365A2/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005073184A1 (fr) * | 2004-01-08 | 2005-08-11 | Genfit | Composes derives de 1,3-diphenylprop-2-en-1-one, preparation et utilisations |
WO2006041197A1 (fr) * | 2004-10-14 | 2006-04-20 | Nippon Chemiphar Co., Ltd. | AGENT ACTIVANT DU RÉCEPTEUR δ ACTIVÉ PAR LES PROLIFÉRATEURS DE PEROXYSOME |
FR2882359A1 (fr) * | 2005-02-24 | 2006-08-25 | Negma Lerads Soc Par Actions S | Derives activateurs de ppar, procede de preparation et application en therapeutique |
CN1861560A (zh) * | 2005-05-13 | 2006-11-15 | 中国科学院上海药物研究所 | 一类羧酸衍生物,其制备方法及药物组合物 |
Non-Patent Citations (2)
Title |
---|
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; SAKUMA, SHOGO ET AL: "Preparation of benzene derivatives containing carboxylic acid moiety as PPAR .delta. activators", XP002446368, retrieved from STN Database accession no. 2006:366960 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; SHEN, JIANHUA ET AL: "Preparation of carboxylic acid derivatives for treatment of type II diabetes", XP002446405, retrieved from STN Database accession no. 2006:1221676 * |
Also Published As
Publication number | Publication date |
---|---|
FR2910892A1 (fr) | 2008-07-04 |
WO2008087365A2 (fr) | 2008-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008087365A3 (fr) | Derives de 1,3-diphenylpropane substitues, preparations et utilisations | |
WO2008087367A3 (fr) | Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations | |
CY1115414T1 (el) | Παραγωγα υποκατεστημενου 1-3-διφαινυλπροπανιου, παρασκευες και χρησεις αυτων | |
WO2008087366A3 (fr) | Derives de 3-phenyl-1-(phenylthienyl)propan-1-one et de 3-phenyl-1-(phenylfuranyl)propan-1-one substitues, preparation et utilisation | |
WO2007038459A3 (fr) | Composes de carboxyamine et leurs methodes d'utilisation | |
WO2006059234A3 (fr) | Amides bicycliques comme inhibiteurs de kinases | |
NO20090348L (no) | Substituerte imidazolonderivater, sammensetninger og anvendelser av samme, samt fremgangsmater for fremstilling av samme | |
IL204732A (en) | @@@@@ - Diplooro - @@ - Deoxy @ tetrahydro uridines, preparations containing them and their use in making @ drugs | |
WO2010001169A3 (fr) | Composés chimiques 251 | |
WO2007118963A3 (fr) | Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations | |
WO2007093880A3 (fr) | Nouveaux dérivés d'indolopyrone et leur procédé de préparation | |
TW200745043A (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
WO2007009721A3 (fr) | Derives de pyrazoline substitues indoline, preparation et utilisation comme medicaments | |
WO2006035157A3 (fr) | Composes derives de n- (benzyl) phenylacetamide substitues , preparation et utilisations comme ligands des ppar dans le traitement des dereglements lipidiques et/ou glucidiques | |
WO2008093075A3 (fr) | Dérivés de 5,6,7,8-tétrahydroptéridine comme inhibiteurs de hsp90 | |
EP2042494A4 (fr) | Composés de thiazole 2,4,5-trisubstitués, méthodes de préparation, compositions pharmaceutiques et leurs utilisations à des fins médicales | |
WO2007009701A3 (fr) | Utilisation de composes pyrazoliniques substitues pour traiter des facteurs de risque cardiovasculaires imputables a des troubles du metabolisme ou de l'alimentation | |
WO2007012479A3 (fr) | Composes | |
WO2004091591A3 (fr) | Composition nutritionnelle ou therapeutique contenant le compose oleurofeine ou l'un de ses derives | |
WO2009053628A3 (fr) | Nouveaux composes, préparation et utilisations | |
WO2007009686A3 (fr) | Composes de pyrazoline substituee, preparation et utilisation de ceux-ci comme medicaments | |
EP2196463A4 (fr) | Procédé de préparation d'acide 5,6-diméthylxanthone-acétique, dérivés ainsi obtenus et formulations pharmaceutiques de ceux-ci | |
SE0300457D0 (sv) | Novel compounds | |
WO2006138431A3 (fr) | Procedes et preparations pharmaceutiques pour l'accroissement de la biodisponibilite | |
WO2006103119A3 (fr) | Nouveaux inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation dans des medicaments administrables aux hommes et aussi dans les cosmetiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07872037 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07872037 Country of ref document: EP Kind code of ref document: A2 |